This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Walgreens Presents Growth Strategy At 2013 Annual Shareholders Meeting

Reviewing a challenging but strategically important year for Walgreens (NYSE: WAG) (Nasdaq: WAG), Chairman James A. Skinner, President and Chief Executive Officer Gregory D. Wasson and Executive Vice President, Chief Financial Officer and President, International Wade D. Miquelon today outlined how the company is positioned for growth in fiscal year 2013 at Walgreens Annual Shareholders Meeting. Addressing more than 2,000 shareholders in Chicago, company leadership discussed the substantial progress Walgreens is making toward its vision to be the first choice in health and daily living in America – and beyond.

Wasson said, “With a strong foundation and the right strategies, structure and talent in place, and with many of last year’s headwinds becoming this year’s tailwinds, Walgreens is well-positioned to ensure its market leadership, growth and profitability well into the future on behalf of its customers and shareholders.”

Having reached new, multi-year agreements with pharmacy benefit managers Express Scripts, Optum Health and others, Walgreens is focused on three areas of opportunity ahead:
  • Delivering a complete Well Experience by transforming the customer experience across all of the company’s touch points, channels and formats
  • Transforming the role community pharmacy plays in health care by offering unparalleled access to innovative, high quality and affordable health and wellness services
  • Creating an unprecedented and efficient global platform through its strategic partnership with Alliance Boots GmbH

“We are taking a multi-pronged approach to delivering the Well Experience,” Wasson said. “We are combining leading-edge design with enhanced products and services, increased engagement with team members and customers, and an omni-channel approach that blends our brick-and-mortar stores with e-commerce and mobile commerce. We are deliberately blurring many retail channels to fit how consumers shop today.”

To that end, Walgreens has continued to expand its product offerings, including:
  • Expanded grocery items and fresh food in stores for on-the-go consumers with quick, convenient pickup, and a growing selection of healthy food choices that are important to underserved food desert communities.
  • Substantial investment continues in private brands, including Walgreens, Delish, Nice! and many more that have led to a 2 percentage points increase in private brand penetration year-over-year to 22 percent.
  • Enhanced beauty departments that now include an array of niche and prestige brands not found in traditional drugstores, including the introduction of Boots No7.
  • And mobile device capabilities that have expanded in the past year to include prescription refills and transfers by scanning the pill bottle; QuickPrints, an application that enables users to print photos directly from their devices to any Walgreens store; and in-store maps that allow customers to use a digital shopping list to map and locate items in a store.

Walgreens efforts to transform the role community pharmacy plays in health care begins with its pharmacists, who are seen more and more by patients as health care partners. Wasson said, “Walgreens pharmacists have administered more than 5 million flu shots in each of the past four years and today we are the largest retail provider of immunizations and vaccinations in the country, which validates that the public appreciates, wants and values what community pharmacy can do to support their health.”

1 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs